Ph.D. Reza Zadno - 17 Sep 2021 Form 4 Insider Report for PROCEPT BioRobotics Corp (PRCT)

Role: President, CEO, Director
Signature: /s/ Alaleh Nouri, Attorney-in-Fact for Reza Zadno, MD
Issuer symbol: PRCT
Transactions as of: 17 Sep 2021
Net transactions value: $0
Form type: 4
Filing time: 21 Sep 2021, 18:35:21 UTC
Previous filing: 14 Sep 2021
Next filing: 04 Apr 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PRCT	Common Stock	Conversion of derivative security		+3,394	+6.4%		56,025	17 Sep 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PRCT	Series F Convertible Preferred Stock	Conversion of derivative security		-3,394	-100%		0	17 Sep 2021	Common Stock	3,394	$0.000000	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock will convert automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares had no expiration date.